← TagsCompany

Eli Lilly

67 articles

Eli Lilly to Acquire Calytrix Bio for Up to $1.5 Billion

Eli Lilly has agreed to acquire Calytrix Bio for up to $1.5 billion to expand its rare blood cancer treatment pipeline. This acquisition strengthens Lilly's hematology portfolio and diversifies revenu

reuters · 2026-11-16 04:19

Antares Therapeutics tackles brand-new protein pockets

Antares Therapeutics secured $177 million in Series A funding to develop small-molecule drugs targeting novel protein pockets, founded by former Scorpion Therapeutics executives after Eli Lilly acquir

cen · 2026-10-12 00:00

Weight-loss-drug makers unveil new data and deals

Major pharmaceutical firms like Eli Lilly are advancing next-generation weight-loss molecules targeting GLP-1 and GIP receptors, building on current blockbusters like Zepbound and Mounjaro while seeki

cen · 2026-09-30 00:00

Novo Nordisk launches Wegovy weight-loss pill in Germany

Novo Nordisk launched its oral Wegovy weight-loss pill in Germany following EU approval, intensifying competition with Eli Lilly in the expanding GLP-1 market. This semaglutide-based treatment targets

reuters · 2026-09-01 01:55

Eli Lilly Launches Oral Weight-Loss Pill Foundayo in UK

Eli Lilly launched its oral weight-loss drug Foundayo (orforglipron) in the UK, marking the first European availability and offering a lower price point than injectable alternatives while pending EU r

reuters · 2026-08-23 16:07
Tag: Eli Lilly — ChemBrief Topics